Nathan De Beule

Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Khê Hoang‐Xuan, Luc Taillandier, Olivier Chinot et al. · Journal of Clinical Oncology · 2003 · 262 citations

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972

Martin J. van den Bent, Olivier Chinot, Willem Boogerd et al. · Annals of Oncology · 2003 · 165 citations · Full text

Neuro-oncology, Recurrent Oligodendroglioma, Oncology +10

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells

Jinheng Wang, Kim De Veirman, Nathan De Beule et al. · Oncotarget · 2015 · 146 citations · Full text

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

Kim De Veirman, Jo A. Van Ginderachter, Susanne Lub et al. · Oncotarget · 2015 · 70 citations · Full text

Immunology, Immunotherapy, Tumor Biology +16

Tumour‐associated macrophage‐mediated survival of myeloma cells through <scp>STAT3</scp> activation

Nathan De Beule, Kim De Veirman, Ken Maes et al. · The Journal of Pathology · 2016 · 64 citations